Exploration of the longitudinal clinical course and potential prognostic factors in Parkinson’s disease: 2.5-year observational study in Japan
By
Kei-ichi Ishikawa
Yushin Tominaga
Yu Kigoshi-Tansho
Kentaro Ohta
Ayami Suzuki
Yuanzhe Li
Wado Akamatsu
Shinji Saiki
Nobutaka Hattori
May 26, 2026
Clinical Report: Long-Term Clinical Progression in Parkinson’s Disease in Japan
Overview {'add': 'Clarify significance of stable UPDRS scores.', 'remove': '', 'modify': ''}
Background {'add': 'Discuss implications of knowledge gap.', 'remove': '', 'modify': ''}
Data Highlights {'add': 'Context for values in the table.', 'remove': '', 'modify': 'Ensure correct formatting.'}
Key Findings {'add': 'Statistical significance of findings.', 'remove': '', 'modify': ''}
Clinical Implications {'add': 'Implementation strategies for timely referrals.', 'remove': '', 'modify': ''}
Conclusion {'add': 'Impact on clinical practice.', 'remove': '', 'modify': ''}
Related Resources & Content
Author(s)/Org, Source, Year -- Title Author(s)/Org, Source, Year -- Title Author(s)/Org, Source, Year -- Title Author(s)/Org, Source, Year -- Title Author(s)/Org, Source, Year -- Title Acta Neuropathologica — Structural Adaptations in the Motor Cortex and White Matter Associated with Parkinson’s Disease Clinical investigation of medicinal products in the treatment of Parkinson's disease - Scientific guideline Rate of motor progression in Parkinson’s disease: a systematic review and meta-analysis Update on Treatments for Parkinson's Disease Motor Fluctuations – An International Parkinson and Movement Disorder Society Evidence‐Based Medicine Review - PMC Pharmacotherapy of motor symptoms in early and mid-stage Parkinson’s disease: guideline “Parkinson’s disease” of the German Society of Neurology | Journal of Neurology | Springer Nature Link Serum neurofilament light at diagnosis: a prognostic indicator for accelerated disease progression in Parkinson’s Disease | npj Parkinson's Disease Prodromal Parkinson’s disease and subsequent risk of Parkinson’s disease and mortality | npj Parkinson's Disease Systematic review of prognostic models in Parkinson’s disease | npj Parkinson's Disease Trial of Lixisenatide in Early Parkinson’s Disease | New England Journal of Medicine Efficacy and safety of GLP-1 agonists in Parkinson’s disease: a systematic review and meta-analysis of randomized controlled trials | Naunyn-Schmiedeberg's Archives of Pharmacology | Springer Nature Link
